The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Human Injection Flu Vaccine Market Research Report 2024
Synopsis
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
The global Human Injection Flu Vaccine market was valued at US$ 7635 million in 2023 and is anticipated to reach US$ 10970 million by 2030, witnessing a CAGR of 5.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Human Injection Flu Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Injection Flu Vaccine.
Report Scope
The Human Injection Flu Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Injection Flu Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Injection Flu Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
Jiangsu GDK
KM Biologics
Segment by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Segment by Application
6 Months to 3 Years
> 3 Years
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Injection Flu Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Injection Flu Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
The global Human Injection Flu Vaccine market was valued at US$ 7635 million in 2023 and is anticipated to reach US$ 10970 million by 2030, witnessing a CAGR of 5.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Human Injection Flu Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Injection Flu Vaccine.
Report Scope
The Human Injection Flu Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Injection Flu Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Injection Flu Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
Jiangsu GDK
KM Biologics
Segment by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Segment by Application
6 Months to 3 Years
> 3 Years
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Injection Flu Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Injection Flu Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Human Injection Flu Vaccine Market Overview
1.1 Product Overview and Scope of Human Injection Flu Vaccine
1.2 Human Injection Flu Vaccine Segment by Type
1.2.1 Global Human Injection Flu Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Human Injection Flu Vaccine Segment by Application
1.3.1 Global Human Injection Flu Vaccine Market Value by Application: (2024-2030)
1.3.2 6 Months to 3 Years
1.3.3 > 3 Years
1.4 Global Human Injection Flu Vaccine Market Size Estimates and Forecasts
1.4.1 Global Human Injection Flu Vaccine Revenue 2019-2030
1.4.2 Global Human Injection Flu Vaccine Sales 2019-2030
1.4.3 Global Human Injection Flu Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Human Injection Flu Vaccine Market Competition by Manufacturers
2.1 Global Human Injection Flu Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Human Injection Flu Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Human Injection Flu Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Human Injection Flu Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Injection Flu Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Injection Flu Vaccine, Product Type & Application
2.7 Human Injection Flu Vaccine Market Competitive Situation and Trends
2.7.1 Human Injection Flu Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Injection Flu Vaccine Players Market Share by Revenue
2.7.3 Global Human Injection Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Injection Flu Vaccine Retrospective Market Scenario by Region
3.1 Global Human Injection Flu Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Human Injection Flu Vaccine Global Human Injection Flu Vaccine Sales by Region: 2019-2030
3.2.1 Global Human Injection Flu Vaccine Sales by Region: 2019-2024
3.2.2 Global Human Injection Flu Vaccine Sales by Region: 2025-2030
3.3 Global Human Injection Flu Vaccine Global Human Injection Flu Vaccine Revenue by Region: 2019-2030
3.3.1 Global Human Injection Flu Vaccine Revenue by Region: 2019-2024
3.3.2 Global Human Injection Flu Vaccine Revenue by Region: 2025-2030
3.4 North America Human Injection Flu Vaccine Market Facts & Figures by Country
3.4.1 North America Human Injection Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Human Injection Flu Vaccine Sales by Country (2019-2030)
3.4.3 North America Human Injection Flu Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Human Injection Flu Vaccine Market Facts & Figures by Country
3.5.1 Europe Human Injection Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Human Injection Flu Vaccine Sales by Country (2019-2030)
3.5.3 Europe Human Injection Flu Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Injection Flu Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Human Injection Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Human Injection Flu Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Human Injection Flu Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Human Injection Flu Vaccine Market Facts & Figures by Country
3.7.1 Latin America Human Injection Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Human Injection Flu Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Human Injection Flu Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Injection Flu Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Injection Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Human Injection Flu Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Human Injection Flu Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Human Injection Flu Vaccine Sales by Type (2019-2030)
4.1.1 Global Human Injection Flu Vaccine Sales by Type (2019-2024)
4.1.2 Global Human Injection Flu Vaccine Sales by Type (2025-2030)
4.1.3 Global Human Injection Flu Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Human Injection Flu Vaccine Revenue by Type (2019-2030)
4.2.1 Global Human Injection Flu Vaccine Revenue by Type (2019-2024)
4.2.2 Global Human Injection Flu Vaccine Revenue by Type (2025-2030)
4.2.3 Global Human Injection Flu Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Human Injection Flu Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Human Injection Flu Vaccine Sales by Application (2019-2030)
5.1.1 Global Human Injection Flu Vaccine Sales by Application (2019-2024)
5.1.2 Global Human Injection Flu Vaccine Sales by Application (2025-2030)
5.1.3 Global Human Injection Flu Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Human Injection Flu Vaccine Revenue by Application (2019-2030)
5.2.1 Global Human Injection Flu Vaccine Revenue by Application (2019-2024)
5.2.2 Global Human Injection Flu Vaccine Revenue by Application (2025-2030)
5.2.3 Global Human Injection Flu Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Human Injection Flu Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Human Injection Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Human Injection Flu Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 CSL
6.2.1 CSL Corporation Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Human Injection Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CSL Human Injection Flu Vaccine Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 GSK
6.3.1 GSK Corporation Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Human Injection Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 GSK Human Injection Flu Vaccine Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Viatris
6.4.1 Viatris Corporation Information
6.4.2 Viatris Description and Business Overview
6.4.3 Viatris Human Injection Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Viatris Human Injection Flu Vaccine Product Portfolio
6.4.5 Viatris Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Corporation Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Human Injection Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 AstraZeneca Human Injection Flu Vaccine Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Hualan Bio
6.6.1 Hualan Bio Corporation Information
6.6.2 Hualan Bio Description and Business Overview
6.6.3 Hualan Bio Human Injection Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Hualan Bio Human Injection Flu Vaccine Product Portfolio
6.6.5 Hualan Bio Recent Developments/Updates
6.7 Changchun Institute of Biological
6.6.1 Changchun Institute of Biological Corporation Information
6.6.2 Changchun Institute of Biological Description and Business Overview
6.6.3 Changchun Institute of Biological Human Injection Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Changchun Institute of Biological Human Injection Flu Vaccine Product Portfolio
6.7.5 Changchun Institute of Biological Recent Developments/Updates
6.8 Sinovac
6.8.1 Sinovac Corporation Information
6.8.2 Sinovac Description and Business Overview
6.8.3 Sinovac Human Injection Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sinovac Human Injection Flu Vaccine Product Portfolio
6.8.5 Sinovac Recent Developments/Updates
6.9 Jiangsu GDK
6.9.1 Jiangsu GDK Corporation Information
6.9.2 Jiangsu GDK Description and Business Overview
6.9.3 Jiangsu GDK Human Injection Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Jiangsu GDK Human Injection Flu Vaccine Product Portfolio
6.9.5 Jiangsu GDK Recent Developments/Updates
6.10 KM Biologics
6.10.1 KM Biologics Corporation Information
6.10.2 KM Biologics Description and Business Overview
6.10.3 KM Biologics Human Injection Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 KM Biologics Human Injection Flu Vaccine Product Portfolio
6.10.5 KM Biologics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Injection Flu Vaccine Industry Chain Analysis
7.2 Human Injection Flu Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Injection Flu Vaccine Production Mode & Process
7.4 Human Injection Flu Vaccine Sales and Marketing
7.4.1 Human Injection Flu Vaccine Sales Channels
7.4.2 Human Injection Flu Vaccine Distributors
7.5 Human Injection Flu Vaccine Customers
8 Human Injection Flu Vaccine Market Dynamics
8.1 Human Injection Flu Vaccine Industry Trends
8.2 Human Injection Flu Vaccine Market Drivers
8.3 Human Injection Flu Vaccine Market Challenges
8.4 Human Injection Flu Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Human Injection Flu Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Human Injection Flu Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Human Injection Flu Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Human Injection Flu Vaccine Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Human Injection Flu Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Human Injection Flu Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Human Injection Flu Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Human Injection Flu Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Human Injection Flu Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Human Injection Flu Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Human Injection Flu Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Human Injection Flu Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Injection Flu Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Injection Flu Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Injection Flu Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Human Injection Flu Vaccine Sales by Region (2019-2024) & (K Units)
Table 18. Global Human Injection Flu Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Human Injection Flu Vaccine Sales by Region (2025-2030) & (K Units)
Table 20. Global Human Injection Flu Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Human Injection Flu Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Human Injection Flu Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Human Injection Flu Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Human Injection Flu Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Human Injection Flu Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Human Injection Flu Vaccine Sales by Country (2019-2024) & (K Units)
Table 27. North America Human Injection Flu Vaccine Sales by Country (2025-2030) & (K Units)
Table 28. North America Human Injection Flu Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Human Injection Flu Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Human Injection Flu Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Human Injection Flu Vaccine Sales by Country (2019-2024) & (K Units)
Table 32. Europe Human Injection Flu Vaccine Sales by Country (2025-2030) & (K Units)
Table 33. Europe Human Injection Flu Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Human Injection Flu Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Human Injection Flu Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Human Injection Flu Vaccine Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Human Injection Flu Vaccine Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Human Injection Flu Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Human Injection Flu Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Human Injection Flu Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Human Injection Flu Vaccine Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Human Injection Flu Vaccine Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Human Injection Flu Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Human Injection Flu Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Human Injection Flu Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Human Injection Flu Vaccine Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Human Injection Flu Vaccine Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Human Injection Flu Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Human Injection Flu Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Human Injection Flu Vaccine Sales (K Units) by Type (2019-2024)
Table 51. Global Human Injection Flu Vaccine Sales (K Units) by Type (2025-2030)
Table 52. Global Human Injection Flu Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Human Injection Flu Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Human Injection Flu Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Human Injection Flu Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Human Injection Flu Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Human Injection Flu Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Human Injection Flu Vaccine Price (US$/Unit) by Type (2019-2024)
Table 59. Global Human Injection Flu Vaccine Price (US$/Unit) by Type (2025-2030)
Table 60. Global Human Injection Flu Vaccine Sales (K Units) by Application (2019-2024)
Table 61. Global Human Injection Flu Vaccine Sales (K Units) by Application (2025-2030)
Table 62. Global Human Injection Flu Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Human Injection Flu Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Human Injection Flu Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Human Injection Flu Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Human Injection Flu Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Human Injection Flu Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Human Injection Flu Vaccine Price (US$/Unit) by Application (2019-2024)
Table 69. Global Human Injection Flu Vaccine Price (US$/Unit) by Application (2025-2030)
Table 70. Sanofi Corporation Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Human Injection Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Sanofi Human Injection Flu Vaccine Product
Table 74. Sanofi Recent Developments/Updates
Table 75. CSL Corporation Information
Table 76. CSL Description and Business Overview
Table 77. CSL Human Injection Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. CSL Human Injection Flu Vaccine Product
Table 79. CSL Recent Developments/Updates
Table 80. GSK Corporation Information
Table 81. GSK Description and Business Overview
Table 82. GSK Human Injection Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. GSK Human Injection Flu Vaccine Product
Table 84. GSK Recent Developments/Updates
Table 85. Viatris Corporation Information
Table 86. Viatris Description and Business Overview
Table 87. Viatris Human Injection Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Viatris Human Injection Flu Vaccine Product
Table 89. Viatris Recent Developments/Updates
Table 90. AstraZeneca Corporation Information
Table 91. AstraZeneca Description and Business Overview
Table 92. AstraZeneca Human Injection Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. AstraZeneca Human Injection Flu Vaccine Product
Table 94. AstraZeneca Recent Developments/Updates
Table 95. Hualan Bio Corporation Information
Table 96. Hualan Bio Description and Business Overview
Table 97. Hualan Bio Human Injection Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Hualan Bio Human Injection Flu Vaccine Product
Table 99. Hualan Bio Recent Developments/Updates
Table 100. Changchun Institute of Biological Corporation Information
Table 101. Changchun Institute of Biological Description and Business Overview
Table 102. Changchun Institute of Biological Human Injection Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Changchun Institute of Biological Human Injection Flu Vaccine Product
Table 104. Changchun Institute of Biological Recent Developments/Updates
Table 105. Sinovac Corporation Information
Table 106. Sinovac Description and Business Overview
Table 107. Sinovac Human Injection Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Sinovac Human Injection Flu Vaccine Product
Table 109. Sinovac Recent Developments/Updates
Table 110. Jiangsu GDK Corporation Information
Table 111. Jiangsu GDK Description and Business Overview
Table 112. Jiangsu GDK Human Injection Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Jiangsu GDK Human Injection Flu Vaccine Product
Table 114. Jiangsu GDK Recent Developments/Updates
Table 115. KM Biologics Corporation Information
Table 116. KM Biologics Description and Business Overview
Table 117. KM Biologics Human Injection Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. KM Biologics Human Injection Flu Vaccine Product
Table 119. KM Biologics Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Human Injection Flu Vaccine Distributors List
Table 123. Human Injection Flu Vaccine Customers List
Table 124. Human Injection Flu Vaccine Market Trends
Table 125. Human Injection Flu Vaccine Market Drivers
Table 126. Human Injection Flu Vaccine Market Challenges
Table 127. Human Injection Flu Vaccine Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Human Injection Flu Vaccine
Figure 2. Global Human Injection Flu Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Human Injection Flu Vaccine Market Share by Type in 2023 & 2030
Figure 4. Trivalent Influenza Vaccine Product Picture
Figure 5. Quadrivalent Influenza Vaccine Product Picture
Figure 6. Global Human Injection Flu Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Human Injection Flu Vaccine Market Share by Application in 2023 & 2030
Figure 8. 6 Months to 3 Years
Figure 9. > 3 Years
Figure 10. Global Human Injection Flu Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Human Injection Flu Vaccine Market Size (2019-2030) & (US$ Million)
Figure 12. Global Human Injection Flu Vaccine Sales (2019-2030) & (K Units)
Figure 13. Global Human Injection Flu Vaccine Average Price (US$/Unit) & (2019-2030)
Figure 14. Human Injection Flu Vaccine Report Years Considered
Figure 15. Human Injection Flu Vaccine Sales Share by Manufacturers in 2023
Figure 16. Global Human Injection Flu Vaccine Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Human Injection Flu Vaccine Players: Market Share by Revenue in 2023
Figure 18. Human Injection Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Human Injection Flu Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Human Injection Flu Vaccine Sales Market Share by Country (2019-2030)
Figure 21. North America Human Injection Flu Vaccine Revenue Market Share by Country (2019-2030)
Figure 22. U.S. Human Injection Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Human Injection Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Human Injection Flu Vaccine Sales Market Share by Country (2019-2030)
Figure 25. Europe Human Injection Flu Vaccine Revenue Market Share by Country (2019-2030)
Figure 26. Germany Human Injection Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Human Injection Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Human Injection Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Human Injection Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Human Injection Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Human Injection Flu Vaccine Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Human Injection Flu Vaccine Revenue Market Share by Region (2019-2030)
Figure 33. China Human Injection Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Human Injection Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Human Injection Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Human Injection Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Human Injection Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan Human Injection Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Human Injection Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Human Injection Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Human Injection Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines Human Injection Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Human Injection Flu Vaccine Sales Market Share by Country (2019-2030)
Figure 44. Latin America Human Injection Flu Vaccine Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Human Injection Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Human Injection Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Human Injection Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Human Injection Flu Vaccine Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Human Injection Flu Vaccine Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Human Injection Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Human Injection Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. U.A.E Human Injection Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Human Injection Flu Vaccine by Type (2019-2030)
Figure 54. Global Revenue Market Share of Human Injection Flu Vaccine by Type (2019-2030)
Figure 55. Global Human Injection Flu Vaccine Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Human Injection Flu Vaccine by Application (2019-2030)
Figure 57. Global Revenue Market Share of Human Injection Flu Vaccine by Application (2019-2030)
Figure 58. Global Human Injection Flu Vaccine Price (US$/Unit) by Application (2019-2030)
Figure 59. Human Injection Flu Vaccine Value Chain
Figure 60. Human Injection Flu Vaccine Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
